Nonalcoholic fatty liver disease: cause or consequence of insulin resistance?

Código QR

Nonalcoholic fatty liver disease: cause or consequence of insulin resistance?

Nonalcoholic fatty liver disease (NAFLD) and type 2 diabetes mellitus (T2DM) are pathological conditions that are co-occurring, and have been reaching epidemic proportions. One of the most significant risk factors for the development of both T2DM and NAFLD is obesity, which increases existing insuli...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Ekaterina E. Mishina, Alexander Y. Mayorov, Pavel O. Bogomolov, Maria V. Matsievich, Ksenia Y. Kokina, Apollinariya V. Bogolyubova
Formato:	article
Lenguaje:	EN RU
Publicado:	Endocrinology Research Centre 2017
Materias:	insulin resistance diabetes mellitus nonalcoholic fatty liver disease nonalcoholic steatohepatitis obesity Nutritional diseases. Deficiency diseases RC620-627
Acceso en línea:	https://doaj.org/article/3d1191129ff645dcbb017e7f0dab037a
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Farnesoid X receptor (FXR) as a potential therapeutic target in nonalcoholic fatty liver disease and associated syndromes
por: Apollinariya V. Bogolyubova, et al.
Publicado: (2017)

Association of insulin resistance and non-alcoholic fatty liver disease
por: Ekaterina E. Mishina, et al.
Publicado: (2021)

EXPRESSION OF TLR2, TLR3, TLR4 AND PROINFLAMMATORY TNF AND IL-6 CYTOKINES IN LIVER BIOPSIES OF NONALCOHOLIC FATTY LIVER DISEASE PATIENTS
por: A. V. Bogolyubova, et al.
Publicado: (2019)

Novel insights into the relationship between nonalcoholic fatty liver disease and osteoporosis
por: Filip R, et al.
Publicado: (2018)

Risk factors of nonalcoholic fatty liver disease in lean body mass population: A systematic review and meta‐analysis
por: Shahinul Alam, et al.
Publicado: (2021)

Role of oxidative stress and glutathione system in the pathogenesis of nonalcoholic fatty liver disease
por: T. E. Promenasheva, et al.
Publicado: (2014)

White Adipose Tissue Autophagy and Adipose-Liver Crosstalk Exacerbate Nonalcoholic Fatty Liver Disease in MiceSummary
por: Sadatsugu Sakane, et al.
Publicado: (2021)

Autophagy: a new target for nonalcoholic fatty liver disease therapy
por: Mao YQ, et al.
Publicado: (2016)

Ileal Bile Acid Transporter Inhibitor Improves Hepatic Steatosis by Ameliorating Gut Microbiota Dysbiosis in NAFLD Model Mice
por: Masahiro Matsui, et al.
Publicado: (2021)

Endotoxin Producers Overgrowing in Human Gut Microbiota as the Causative Agents for Nonalcoholic Fatty Liver Disease
por: Na Fei, et al.
Publicado: (2020)

Cholesterol Metabolism: A Double-Edged Sword in Hepatocellular Carcinoma
por: Fangli Zhou, et al.
Publicado: (2021)

PNPLA3 genotype and fibrosis-4 index predict cardiovascular diseases of Japanese patients with histopathologically-confirmed NAFLD
por: Norio Akuta, et al.
Publicado: (2021)

Identification of key genes and pathways in mild and severe nonalcoholic fatty liver disease by integrative analysis
por: Jin Feng, et al.
Publicado: (2021)

Liraglutide ameliorates nonalcoholic fatty liver disease in diabetic mice via the IRS2/PI3K/Akt signaling pathway
por: Yang P, et al.
Publicado: (2019)

Analysis of prevalence of risk factor of nonalcoholic fatty liver disease in the Buryat Republic
por: E. G. Naydanova
Publicado: (2015)

Nonalcoholic fatty liver disease (NAFLD) – a new factor that interplays between inflammation, malnutrition, and atherosclerosis in elderly hemodialysis patients
por: Mikolasevic I, et al.
Publicado: (2014)

Activated Natural Killer Cell Promotes Nonalcoholic Steatohepatitis Through Mediating JAK/STAT PathwaySummary
por: Feixue Wang, et al.
Publicado: (2022)

Biochanin A Regulates Cholesterol Metabolism Further Delays the Progression of Nonalcoholic Fatty Liver Disease
por: Fan Y, et al.
Publicado: (2021)

E-Selectin-Dependent Inflammation and Lipolysis in Adipose Tissue Exacerbate Steatosis-to-NASH Progression via S100A8/9Summary
por: Robim M. Rodrigues, et al.
Publicado: (2022)

Relationship between obesity, metabolic syndrome, and nonalcoholic fatty liver disease in the elderly agricultural and fishing population of Taiwan
por: Shen HC, et al.
Publicado: (2014)

Association Between the Triglyceride–Glucose Index and Outcomes of Nonalcoholic Fatty Liver Disease: A Large-Scale Health Management Cohort Study
por: Liu J, et al.
Publicado: (2021)

Therapeutic Effects of Garlic on Hepatic Steatosis in Nonalcoholic Fatty Liver Disease Patients: A Randomized Clinical Trial
por: Soleimani D, et al.
Publicado: (2020)

Correlation Between Psoriasis Severity and Nonalcoholic Fatty Liver Disease Degree Measured Using Controlled Attenuation Parameter
por: Gandha N, et al.
Publicado: (2020)

Liver biopsy in the quantitative assessment of liver fibrosis in nonalcoholic fatty liver disease
por: Gwyneth Shook Ting Soon, et al.
Publicado: (2021)

Gallstone disease and nonalcoholic fatty liver disease in patients with type 2 diabetes: a cross-sectional study
por: Ye Lu, et al.
Publicado: (2021)

Effects of duodenal–jejunal bypass surgery in ameliorating nonalcoholic steatohepatitis in diet-induced obese rats
por: Yu HH, et al.
Publicado: (2019)

Association between Equol Production Status and Nonalcoholic Steatohepatitis
por: Takemi Akahane, et al.
Publicado: (2021)

Aqueous Metabolite Trends for the Progression of Nonalcoholic Fatty Liver Disease in Female Bariatric Surgery Patients by Targeted <sup>1</sup>H-NMR Metabolomics
por: Emma J. Robinson, et al.
Publicado: (2021)

A nomogram for predicting metabolic steatohepatitis: The combination of NAMPT, RALGDS, GADD45B, FOSL2, RTP3, and RASD1
por: Liao Shenling, et al.
Publicado: (2021)

Pathophysiological Molecular Mechanisms of Obesity: A Link between MAFLD and NASH with Cardiovascular Diseases
por: Jorge Gutiérrez-Cuevas, et al.
Publicado: (2021)

Estimation of the Prevalence of Nonalcoholic Fatty Liver Disease in an Adult Population in Northern China Using the Data Mining Approach
por: Yang T, et al.
Publicado: (2021)

Electromagnetic Fields Ameliorate Insulin Resistance and Hepatic Steatosis by Modulating Redox Homeostasis and SREBP-1c Expression in db/db Mice
por: Zhai M, et al.
Publicado: (2021)

A Comparative Analysis of Serum Lipids in Patients with Chronic Hepatitis C, Nonalcoholic Fatty Liver Disease and Healthy Controls
por: Valkov I., et al.
Publicado: (2017)

Nonalcoholic Fatty Liver Disease and Risk of Heart Failure Among Medicare Beneficiaries
por: Marat Fudim, et al.
Publicado: (2021)

Testosterone deficiency and non-alcoholic fatty liver disease in men with type 2 diabetes mellitus
por: Irina A. Khripun, et al.
Publicado: (2019)

Nonalcoholic Fatty Liver Disease and Chronic Kidney Disease: A Review of Links and Risks
por: Cheung A, et al.
Publicado: (2021)

Integrative lipidomic and transcriptomic study unravels the therapeutic effects of saikosaponins A and D on non-alcoholic fatty liver disease
por: Xiaojiaoyang Li, et al.
Publicado: (2021)

T Cell Subsets and Natural Killer Cells in the Pathogenesis of Nonalcoholic Fatty Liver Disease
por: Yoseph Asmelash Gebru, et al.
Publicado: (2021)

Potential relation between non-alcoholic fatty liver disease and glycemic and metabolic parameters in subjects without diabetes
por: H. Naguib, et al.
Publicado: (2021)

Therapeutic Targeting of Nonalcoholic Fatty Liver Disease by Downregulating SREBP-1C Expression via AMPK-KLF10 Axis
por: Yu-Chi Chen, et al.
Publicado: (2021)